Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

136 Murai R, Yamada K, Tanaka M, Kuribayashi K, Kobayashi D, Tsuji N et al.
Reconstructing a 3-dimensional image of the results of antinuclear antibody testing by
indirect immunofluorescence. J Immunol Methods 2013; 387: 312–316.
137 Grossmann K, Roggenbuck D, Schröder C, Conrad K, Schierack P, Sack U. Multiplex
assessment of non-organ-specific autoantibodies with a novel microbead-based
immunoassay. Cytometry A 2011; 79: 118–125.
138 El-Chennawi F a, Mosaad YM, Habib HM, El-Degheidi T. Comparative study of
antinuclear antibody detection by indirect immunofluorescence and enzyme immunoassay
in lupus patients. Immunol Invest 2009; 38: 839–850.
139 Campos-González ID, Viveros ME, Cardiel MH. Utilidad clínica de las pruebas
inmunológicas especializadas en reumatología en un hospital de segundo nivel de atención
en México. Rheumatol Clínica 2007; 3: 110–117.
140 Hahn B. Antibodies to DNA. N Engl J Med 1998; 338: 1359–1369.
141 Barbas SM, Ditzel HJ, Salonen EM, Yang WP, Silverman GJ, Burton DR. Human
autoantibody recognition of DNA. Proc Natl Acad Sci U S A 1995; 92: 2529–2533.
142 Swaak T, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: a prospective study in
441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA).
Ann Rheum Dis 1985; 44: 245–251.
143 Kavanaugh AF, Solomon DH. Guidelines for immunologic laboratory testing in the
rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 2002; 47: 546–555.
144 Bootsma H, Spronk P, Hummel E, de Boer G, ter Borg E, Limburg P et al. Anti-double
stranded DNA antibodies in systemic lupus erythematosus: Detection and clinical
relevance of IgM-class antibodies. Scand J Rheumatol 1996; 25: 352–359.
145 Riboldi P, Gerosa M, Moroni G, Radice A, Allegri F, Sinico A et al. Anti-DNA
antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
Autoimmunity 2005; 38: 39–45.
146 Launay D, Schmidt J, Lepers S, Mirault T, Lambert M, Kyndt X et al. Comparison of the
Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae
immunofluorescence test for diagnosis and activity assessment of systemic lupus
erythematosus. Clin Chim Acta 2010; 411: 959–964.
147 Avina-Zubieta J, Galindo-Rodriguez G, Kwan-Yeung L, Davis P, Russell A. Clinical
evaluation of various selected ELISA kits for the detection of anti-DNA antibodies.
Lupus 1995; 4: 370–374.
148 Werle E, Blazek M, Fiehn W. The clinical significance of measuring different anti-dsDNA
antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae
immunofluorescence test. Lupus 1992; 1: 369–377.
149 Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R et al. Diagnostic
accuracy of currently available anti-double-stranded DNA antibody assays . An Italian
multicentre. Clin Exp Rheumatol 2011; 29: 50–56.
GUÍA DE PRÁCTICA CLÍNICA SOBRE LUPUS ERITEMATOSO SISTÉMICO 445